<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19467" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cholesterol Screening</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sundjaja</surname>
            <given-names>Joshua Henrina</given-names>
          </name>
          <aff>Atma Jaya Catholic University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pandey</surname>
            <given-names>Shivlal</given-names>
          </name>
          <aff>LSU-HSC / Monroe Family Medicine Program</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joshua Henrina Sundjaja declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shivlal Pandey declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19467.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Atherosclerotic cardiovascular disease (ASCVD)&#x000a0;is one of the worldwide leading cause of cardiovascular morbidity and mortality. In 2013 coronary artery disease and cerebrovascular disease were the first and third&#x000a0;causes of death, which&#x000a0;attributed&#x000a0;to 84.5% cardiovascular death and 28.2% of all-cause mortality, respectively.<xref ref-type="bibr" rid="article-19467.r1">[1]</xref> Experts predict these numbers to increase in the future due to the transformation of the human lifestyle, particularly fast-food diet, and sedentary living.<xref ref-type="bibr" rid="article-19467.r2">[2]</xref> It also contributed to substantial morbidity because&#x000a0;coronary heart disease (CHD)&#x000a0;is one of the most important etiology of heart failure, specifically ischemic cardiomyopathy. Due to better healthcare systems and technology, many CHD patients that experienced acute ischemic events survived but later&#x000a0;developed heart failure.<xref ref-type="bibr" rid="article-19467.r3">[3]</xref> The relationship between cholesterol and heart disease is well-established. Therefore, following appropriate guidelines for screening is of paramount importance.</p>
        <p>Cholesterol is a sterol compound found in most human body tissues. From a physiologic standpoint, cholesterol and its derivatives are vitally crucial for cell membranes and myriad metabolic processes in the body. Also, cholesterol is used to make hormones, fat-soluble vitamins, and bile acids. The primary source of cholesterol&#x000a0;is from animal-based foods, such as&#x000a0;eggs, dairy, and cheese.&#x000a0;Based on density, cholesterol can classify as high-density lipoproteins (HDL), low-density lipoproteins (LDL), or very-low-density lipoproteins (VLDL). Triglycerides are also part of the blood-lipid profile.<xref ref-type="bibr" rid="article-19467.r4">[4]</xref>&#x000a0;Of note, LDL, VLDL, and triglycerides have been correlated to increased risk of CHD, while the reverse appears to be true for HDL. Thus, higher HDL levels confer a protective effect on CHD and all-cause mortality.</p>
        <p>Framingham Heart Study, a landmark study, is the first&#x000a0;to&#x000a0;demonstrate unequivocally&#x000a0;that higher LDL concentrations were associated with a higher risk of ASCVD.<xref ref-type="bibr" rid="article-19467.r5">[5]</xref><xref ref-type="bibr" rid="article-19467.r6">[6]</xref><xref ref-type="bibr" rid="article-19467.r7">[7]</xref></p>
      </sec>
      <sec id="article-19467.s2" sec-type="Specimen Collection">
        <title>Specimen Collection</title>
        <p>Traditionally, when patients were scheduling for cholesterol testing, they needed to fast for more than eight hours.<xref ref-type="bibr" rid="article-19467.r8">[8]</xref> The reason behind this laboratory routine is to avoid triglyceride elevation postprandially. However, recently, routine fasting is not&#x000a0;mandatory for every patient before cholesterol testing. Nevertheless, some circumstances require patients&#x000a0;to&#x000a0;fast. Thus, the decision to fast or not to fast depends on the clinical question being asked by the respective physician, as outlined below:</p>
        <list list-type="bullet">
          <list-item>
            <p>Non- fasting blood lipid profiles are acceptable in several conditions, i.e. :<xref ref-type="bibr" rid="article-19467.r9">[9]</xref>
<list list-type="order"><list-item><p>Initial risk estimation of an untreated primary prevention patient</p></list-item><list-item><p>To clarify the diagnosis of metabolic syndrome.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Fasting blood lipid profiles are preferred or even mandatory in several conditions, i.e. :<xref ref-type="bibr" rid="article-19467.r9">[9]</xref>
<list list-type="order"><list-item><p>For screening and following patients with a family history of genetic hyperlipidemia or premature ASCVD (Fasting is mandatory)</p></list-item><list-item><p>Establish the diagnosis of hypertriglyceridemia</p></list-item><list-item><p>Residual risk estimation of treated patients</p></list-item><list-item><p>Assessment of patients with or at risk for pancreatitis&#x000a0;&#x000a0;&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Then, patients will undergo a venous blood sampling of 0.5 to 1 mL, mostly through their antecubital vein. The container for the&#x000a0;specimen must be a gel-barrier transport, green-top (heparin) tube, or&#x000a0;lavender-top (EDTA) tube. Then, the serum must be separated from other blood components within 45 minutes of collection. Samples should be stored at room temperature.&#x000a0;</p>
      </sec>
      <sec id="article-19467.s3" sec-type="Procedures">
        <title>Procedures</title>
        <p>The LDL cholesterol estimation can proceed with two&#x000a0;distinct methods; indirect and direct. The&#x000a0;former approach utilizes the Friedewald cholesterol estimation formula. On the other hand, the latter method utilizes homogeneous assays. In unreliable conditions, such as triglyceride &#x0003e;400 mg/dL, the direct methods can be used to supplement the Friedewald calculation, which has shown to able to meet the standard requirements set by National Cholesterol Education Program (NCEP) for LDL-C testing.&#x000a0;When used for non-fasting samples, the direct method&#x000a0;was precise and accurate (CV &#x0003c;4% and bias &#x0003c;4%).<xref ref-type="bibr" rid="article-19467.r10">[10]</xref>&#x000a0;</p>
        <p>Nonetheless, there were several limitations to direct methods. A study of comparison between direct and indirect methods with the reference&#x000a0;method of the ultracentrifugation in HIV patients, which hypertriglyceridemia are common, found that no adequate agreement between these two tests with the ultracentrifugation. When TG is more than 400 mg/dL, the direct method tends to overestimate the actual LDL, whereas the indirect method tends to underestimate the actual LDL levels.<xref ref-type="bibr" rid="article-19467.r11">[11]</xref></p>
      </sec>
      <sec id="article-19467.s4" sec-type="Indications">
        <title>Indications</title>
        <p>There are many major clinical practice guidelines set by several colleges and societies with their subtle differences between them. However, the primary goals of these clinical practice guidelines are all the same, which&#x000a0;are cholesterol testing to prevent&#x000a0;CAD in healthy populations or primary prevention and to provide early detection and slow down the progression of diseases or secondary prevention.&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Patient with a family history of premature death due to myocardial infarction in first degree relatives (&#x0003c;55 years [male] and &#x0003c;65 years [female])</p>
          </list-item>
          <list-item>
            <p>History of familial hypercholesterolemia or patient with stigmata of familial hypercholesterolemia (xanthoma/ xanthomata or eyelid xanthelasma)</p>
          </list-item>
          <list-item>
            <p>Patients with comorbidities that are likely to be benefitted from statins use, i.e., patients with diabetes, chronic kidney disease, HIV, and others.</p>
          </list-item>
          <list-item>
            <p>Risk stratification for patients without the disease, which might benefit from cholesterol-lowering treatment.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19467.s5" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>Cholesterol screening is an integral part of primary and secondary prevention of ASCVD.&#x000a0;It can detect a vulnerable population that may be asymptomatic but with a high risk of ASCVD due to genetic predispositions. Additionally, it can detect cholesterol elevations secondary to&#x000a0;other diseases, such as diabetes, chronic kidney disease, and HIV infection, or due to drug usage, such as oral contraceptive drugs and others.<xref ref-type="bibr" rid="article-19467.r12">[12]</xref><xref ref-type="bibr" rid="article-19467.r13">[13]</xref> Furthermore, abnormally high levels of cholesterol components might indicate familial hypercholesterolemia.<xref ref-type="bibr" rid="article-19467.r14">[14]</xref><xref ref-type="bibr" rid="article-19467.r15">[15]</xref></p>
        <p>Occasionally, when screening for cardiovascular disease by cholesterol test, the result might reveal low or even untraceable levels of LDL-C. When the LDL is &#x0003c; 80 mg/dL, hypobetalipoproteinemia might be suspected, whereas an undetected level of LDL signifies abetalipoproteinemia.<xref ref-type="bibr" rid="article-19467.r16">[16]</xref><xref ref-type="bibr" rid="article-19467.r17">[17]</xref></p>
      </sec>
      <sec id="article-19467.s6" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>Non-fasting samples*<xref ref-type="bibr" rid="article-19467.r18">[18]</xref></p>
        <list list-type="order">
          <list-item>
            <p>Triglycerides:
<list list-type="bullet"><list-item><p>&#x02265;2 mmol/L (175 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Total cholesterol:
<list list-type="bullet"><list-item><p>&#x02265;5 mmol/L (190 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>LDL cholesterol:
<list list-type="bullet"><list-item><p>&#x02265;3 mmol/L (115 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Remnant cholesterol (IDL + VLDL):&#x000a0;
<list list-type="bullet"><list-item><p>&#x02265;0.9 mmol/L (35 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Non-HDL cholesterol:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02265;3.9 mmol/L (150 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Lipoprotein (a)
<list list-type="bullet"><list-item><p>&#x02265;0.50 g/L (50 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Apolipoprotein B:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02265;1.0 g/L (100 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>HDL cholesterol:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02264;1 mmol/L (40 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Apolipoprotein A1:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02264;1.25 g/L (125 mg/dL)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>*When non-fasting triglycerides concentration exceeds 5mmol/L (440 mg/dL), obtaining a fasting plasma sample may be considered.</p>
        <p>Fasting samples</p>
        <list list-type="order">
          <list-item>
            <p>Triglycerides:
<list list-type="bullet"><list-item><p>&#x02265;1.7 mmol/L (150 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Total cholesterol:
<list list-type="bullet"><list-item><p>&#x02265;5 mmol/L (190 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>LDL cholesterol:
<list list-type="bullet"><list-item><p>&#x02265;3 mmol/L (115 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Remnant cholesterol (IDL + VLDL):&#x000a0;
<list list-type="bullet"><list-item><p>&#x02265;0.8 mmol/L (30 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Non-HDL cholesterol:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02265;3.8 mmol/L (145 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Lipoprotein (a)
<list list-type="bullet"><list-item><p>&#x02265;0.50 g/L (50 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Apolipoprotein B:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02265;1.0 g/L (100 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>HDL cholesterol:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02264;1 mmol/L (40 mg/dL)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Apolipoprotein A1:&#x000a0;
<list list-type="bullet"><list-item><p>&#x02264;1.25 g/L (125 mg/dL)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The&#x000a0;NCEP has also set the LDL-C concentrations and their&#x000a0;respective labels in adult &#x0003e;18 years old, with &#x0003c;100, 100 - 129, 130 - 159, 160 - 189, and &#x0003e;= 190 mg/dL identified as desirable, above desirable, borderline high, high, and very high, respectively.<xref ref-type="bibr" rid="article-19467.r19">[19]</xref>&#x000a0;For children and adolescents, cholesterol concentrations of &#x0003c;110mg/dL, 110 - 129 mg/dL, and &#x0003e;= 130 mg/dL were deemed acceptable, borderline high, and high, respectively.<xref ref-type="bibr" rid="article-19467.r20">[20]</xref></p>
      </sec>
      <sec id="article-19467.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>The&#x000a0;original Friedewald equation is total cholesterol (TC) = HDL + LDL + Triglycerides( TG)/5, and it is comparable to the ultracentrifuge method of lipoprotein quantification. However, three conditions preclude the use of this equation, explain as follows:<xref ref-type="bibr" rid="article-19467.r21">[21]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>The first one is when&#x000a0;there is chylomicron in the plasma. Chylomicrons contain triglycerides; thus, it can interfere with the formula for VLDL calculation, which is plasma TG divided by five. Fortunately, normal subjects do not have chylomicrons in their plasma. Furthermore, chylomicrons can be present in the plasma of patients that suffer type I (familial hyperchylomicronemia), type III (familial dysbetalipoproteinemia), and type V (combined hypertriglyceridemia).</p>
          </list-item>
          <list-item>
            <p>The second one is in type III familial hypercholesterolemia (FH). In this disorder, VLDL exists in two forms, which are the normal VLDL with the ratio of TG to cholesterol around five,&#x000a0; and the unique VLDL which the cholesterol's content is abnormally higher with beta mobility on electrophoresis. Therefore, in type III FH, the method of choice is either by centrifugal isolation of the VLDL, checking cholesterol electrophoresis' mobility,&#x000a0;or by finding the TG/cholesterol ratio.</p>
          </list-item>
          <list-item>
            <p>Finally, when the plasma triglycerides concentration is higher than 400 mg/dL. Friedewald et al. noticed that when they incorporate type IV FH patient cholesterol values, they notice outlier values and the decreased correlation coefficient between ultracentrifuge and estimated cholesterol measurement. Subsequently, they found that some type IV FH patients had TG levels above 400 mg/dL. Consequently, after they excluded these patients' values, the correlation coefficient rose.</p>
          </list-item>
        </list>
        <p>Therefore, a new estimation method is proposed by Martin et al. Their estimation is more accurate because it does not use fix ratio between TG and VLDL, but it incorporates adjustable factors for the ratios of triglyceride and VLDL. Consequently, when the LDL is very low, or the TG is very high, i.e.,&#x0003e;400 mg/dL,&#x000a0;this new estimation gives more accurate results.<xref ref-type="bibr" rid="article-19467.r22">[22]</xref>&#x000a0;This equation has also shown to be superior compared to the Friedewald equation for non-fasting samples.<xref ref-type="bibr" rid="article-19467.r23">[23]</xref></p>
      </sec>
      <sec id="article-19467.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>LDL-C and HDL-C&#x000a0;levels are essential for calculating the 10-year risk of&#x000a0;ASCVD derived from the Lloyd-Jones et al. study, which is applicable for men and women, age 40&#x000a0;to 79, and African American/Non-Hispanic White.<xref ref-type="bibr" rid="article-19467.r24">[24]</xref>&#x000a0;However, for other ethnicities, Non-Hispanic White is used. Nonetheless, it can overestimate or underestimate the risk.<xref ref-type="bibr" rid="article-19467.r25">[25]</xref></p>
        <p>Another risk-estimation tool identified as heart score, which is adopted by the European Society of Cardiology, also incorporates total cholesterol and HDL levels.<xref ref-type="bibr" rid="article-19467.r26">[26]</xref> It derives from a study by Conroy et al., which involved 12 European cohort studies, 250,000 patient-data sets, with 3 million person-years of observation, and 7000 fatal cardiovascular events.<xref ref-type="bibr" rid="article-19467.r27">[27]</xref></p>
      </sec>
      <sec id="article-19467.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19467&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19467">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19467/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19467">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19467.s10">
        <title>References</title>
        <ref id="article-19467.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barquera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pedroza-Tob&#x000ed;as</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Barrera</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bibbins-Domingo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lozano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease.</article-title>
            <source>Arch Med Res</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>328</fpage>
            <page-range>328-38</page-range>
            <pub-id pub-id-type="pmid">26135634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ignarro</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Balestrieri</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Napoli</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Nutrition, physical activity, and cardiovascular disease: an update.</article-title>
            <source>Cardiovasc Res</source>
            <year>2007</year>
            <month>Jan</month>
            <day>15</day>
            <volume>73</volume>
            <issue>2</issue>
            <fpage>326</fpage>
            <page-range>326-40</page-range>
            <pub-id pub-id-type="pmid">16945357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Gibbs</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Beevers</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>ABC of heart failure: aetiology.</article-title>
            <source>BMJ</source>
            <year>2000</year>
            <month>Jan</month>
            <day>08</day>
            <volume>320</volume>
            <issue>7227</issue>
            <fpage>104</fpage>
            <page-range>104-7</page-range>
            <pub-id pub-id-type="pmid">10625270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blesso</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Dietary Cholesterol, Serum Lipids, and Heart Disease: Are Eggs Working for or Against You?</article-title>
            <source>Nutrients</source>
            <year>2018</year>
            <month>Mar</month>
            <day>29</day>
            <volume>10</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">29596318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DAWBER</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>KANNEL</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>LYELL</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>An approach to longitudinal studies in a community: the Framingham Study.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>1963</year>
            <month>May</month>
            <day>22</day>
            <volume>107</volume>
            <fpage>539</fpage>
            <page-range>539-56</page-range>
            <pub-id pub-id-type="pmid">14025561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmood</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vasan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.</article-title>
            <source>Lancet</source>
            <year>2014</year>
            <month>Mar</month>
            <day>15</day>
            <volume>383</volume>
            <issue>9921</issue>
            <fpage>999</fpage>
            <page-range>999-1008</page-range>
            <pub-id pub-id-type="pmid">24084292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Belanger</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Silbershatz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>Prediction of coronary heart disease using risk factor categories.</article-title>
            <source>Circulation</source>
            <year>1998</year>
            <month>May</month>
            <day>12</day>
            <volume>97</volume>
            <issue>18</issue>
            <fpage>1837</fpage>
            <page-range>1837-47</page-range>
            <pub-id pub-id-type="pmid">9603539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Gr&#x000e9;goire</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Couture</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dawes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Genest</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hegele</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Leiter</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Lonn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>McPherson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ngui</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Poirier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sievenpiper</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Thanassoulis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.</article-title>
            <source>Can J Cardiol</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>11</issue>
            <fpage>1263</fpage>
            <page-range>1263-1282</page-range>
            <pub-id pub-id-type="pmid">27712954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Driver</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Gluckman</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Clary</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Fasting or Nonfasting Lipid Measurements: It Depends on the Question.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2016</year>
            <month>Mar</month>
            <day>15</day>
            <volume>67</volume>
            <issue>10</issue>
            <fpage>1227</fpage>
            <page-range>1227-1234</page-range>
            <pub-id pub-id-type="pmid">26965545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nauck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Warnick</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Rifai</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.</article-title>
            <source>Clin Chem</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>236</fpage>
            <page-range>236-54</page-range>
            <pub-id pub-id-type="pmid">11805004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Fichtenbaum</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Aberg</surname>
                <given-names>JA</given-names>
              </name>
              <collab>A5087 Study Team</collab>
            </person-group>
            <article-title>Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087.</article-title>
            <source>HIV Clin Trials</source>
            <year>2007</year>
            <season>Jan-Feb</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-52</page-range>
            <pub-id pub-id-type="pmid">17434848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Herink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <chapter-title>Medication Induced Changes in Lipid and Lipoproteins</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2018</year>
            <month>5</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">26561699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Secondary causes of hyperlipidemia.</article-title>
            <source>Med Clin North Am</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>117</fpage>
            <page-range>117-41</page-range>
            <pub-id pub-id-type="pmid">8283927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brett</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gidding</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>GF</given-names>
              </name>
            </person-group>
            <article-title>Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.</article-title>
            <source>Atherosclerosis</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>277</volume>
            <fpage>399</fpage>
            <page-range>399-406</page-range>
            <pub-id pub-id-type="pmid">30270077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weng</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Kai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andrew Neil</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Humphries</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).</article-title>
            <source>Atherosclerosis</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>238</volume>
            <issue>2</issue>
            <fpage>336</fpage>
            <page-range>336-43</page-range>
            <pub-id pub-id-type="pmid">25555265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welty</surname>
                <given-names>FK</given-names>
              </name>
            </person-group>
            <article-title>Hypobetalipoproteinemia and abetalipoproteinemia.</article-title>
            <source>Curr Opin Lipidol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>161</fpage>
            <page-range>161-8</page-range>
            <pub-id pub-id-type="pmid">24751931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Linton</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Farese</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Familial hypobetalipoproteinemia.</article-title>
            <source>J Lipid Res</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>521</fpage>
            <page-range>521-41</page-range>
            <pub-id pub-id-type="pmid">8496659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nordestgaard</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Langsted</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kolovou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bruckert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Sypniewska</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wiklund</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bor&#x000e9;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cobbaert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Descamps</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>von Eckardstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kamstrup</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Pulkki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kronenberg</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Remaley</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Rifai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ros</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Langlois</surname>
                <given-names>M</given-names>
              </name>
              <collab>European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) joint consensus initiative</collab>
            </person-group>
            <article-title>Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.</article-title>
            <source>Eur Heart J</source>
            <year>2016</year>
            <month>Jul</month>
            <day>01</day>
            <volume>37</volume>
            <issue>25</issue>
            <fpage>1944</fpage>
            <page-range>1944-58</page-range>
            <pub-id pub-id-type="pmid">27122601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <collab>Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults</collab>
            <article-title>Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>May</month>
            <day>16</day>
            <volume>285</volume>
            <issue>19</issue>
            <fpage>2486</fpage>
            <page-range>2486-97</page-range>
            <pub-id pub-id-type="pmid">11368702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <collab>Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents</collab>
            <collab>National Heart, Lung, and Blood Institute</collab>
            <article-title>Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.</article-title>
            <source>Pediatrics</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>128 Suppl 5</volume>
            <issue>Suppl 5</issue>
            <fpage>S213</fpage>
            <page-range>S213-56</page-range>
            <pub-id pub-id-type="pmid">22084329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedewald</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Fredrickson</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.</article-title>
            <source>Clin Chem</source>
            <year>1972</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>499</fpage>
            <page-range>499-502</page-range>
            <pub-id pub-id-type="pmid">4337382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Blaha</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Elshazly</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Toth</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Kwiterovich</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.</article-title>
            <source>JAMA</source>
            <year>2013</year>
            <month>Nov</month>
            <day>20</day>
            <volume>310</volume>
            <issue>19</issue>
            <fpage>2061</fpage>
            <page-range>2061-8</page-range>
            <pub-id pub-id-type="pmid">24240933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sathiyakumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Golozar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lazo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quispe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guallar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Jan</month>
            <day>02</day>
            <volume>137</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-19</page-range>
            <pub-id pub-id-type="pmid">29038168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Leip</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Beiser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Feb</month>
            <day>14</day>
            <volume>113</volume>
            <issue>6</issue>
            <fpage>791</fpage>
            <page-range>791-8</page-range>
            <pub-id pub-id-type="pmid">16461820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grundy</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Beam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Birtcher</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>de Ferranti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Faiella-Tommasino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Forman</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heidenreich</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lopez-Pajares</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ndumele</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Orringer</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Peralta</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Saseen</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Virani</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Yeboah</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task&#x000a0;Force&#x000a0;on&#x000a0;Clinical Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Jun</month>
            <day>25</day>
            <volume>73</volume>
            <issue>24</issue>
            <fpage>3168</fpage>
            <page-range>3168-3209</page-range>
            <pub-id pub-id-type="pmid">30423391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mach</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baigent</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Catapano</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Koskinas</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Casula</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Badimon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ference</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Halliday</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Landmesser</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Mihaylova</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Riccardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Sabatine</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Taskinen</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Tokgozoglu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wiklund</surname>
                <given-names>O</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.</article-title>
            <source>Eur Heart J</source>
            <year>2020</year>
            <month>Jan</month>
            <day>01</day>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-188</page-range>
            <pub-id pub-id-type="pmid">31504418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19467.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conroy</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Py&#x000f6;r&#x000e4;l&#x000e4;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Sans</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Menotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Bacquer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ducimeti&#x000e8;re</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jousilahti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Keil</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Nj&#x000f8;lstad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Oganov</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tunstall-Pedoe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tverdal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wedel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Whincup</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wilhelmsen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>IM</given-names>
              </name>
              <collab>SCORE project group</collab>
            </person-group>
            <article-title>Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.</article-title>
            <source>Eur Heart J</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>987</fpage>
            <page-range>987-1003</page-range>
            <pub-id pub-id-type="pmid">12788299</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
